AI + biobank Introduce the humanelement, sooner The high failure rate in oncology drug development trials hints at a lack of drug-response data in a heterogeneous tumor population. This can impact even the most confident drug-discovery design. But what if you could introduce this valuable data well before clinical trials? With PEDAL you can. Our […]
